TREATMENT METHOD OF LEFT VENTRICULAR DYSFUNCTION FOLLOWING AN ACUTE MYOCARDIAL INFARCTION
The present invention refers to a composition comprising a compound capable of reducing the expression of the Yin Yang 1 (Yy1) gene in cardiac cells of a human or animal subject with respect to the expression observed in the absence of the compound in said cells, wherein the compound is an interfere...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French German |
Published |
12.04.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention refers to a composition comprising a compound capable of reducing the expression of the Yin Yang 1 (Yy1) gene in cardiac cells of a human or animal subject with respect to the expression observed in the absence of the compound in said cells, wherein the compound is an interference RNA (RNAi) of the Yy1 gene, and wherein said compound is for use in the treatment of myocardial fibrosis, cardiac inflammation, cardiac hypertrophy and/or functional impairment 2 to 48 hours after acute myocardial infarction (AMI). |
---|---|
Bibliography: | Application Number: EP20210730620 |